Senior Medical Science Liaison - DMD/Neuromuscular (Southeast)
REGENXBIO
Summary
As a Senior Medical Science Liaison, you'll provide support for REGENXBIO Rare Disease pre-commercial clinical trials and scientific collaborations with a focus on our Duchenne Muscular Dystrophy program. This is an exciting opportunity for an innovative MSL with an entrepreneurial spirit who enjoys building networks, interacting with KOLs, conducting scientific exchange, and supporting scientific conferences.
Job description
The Opportunity
As a Senior Medical Science Liaison, you'll provide support for REGENXBIO Rare Disease pre-commercial clinical trials and scientific collaborations with a focus on our Duchenne Muscular Dystrophy program. This is an exciting opportunity for an innovative MSL with an entrepreneurial spirit who enjoys building networks, interacting with KOLs, conducting scientific exchange, and supporting scientific conferences.
What you'll be doing
- Support clinical trial recruitment and site outreach; communicate coordinated feedback to the Clinical Operations, Clinical Development, and Duchenne Core teams.
- Serve as the field-based Medical Affairs representative to establish and cultivate scientific relationships with KOLs in the Duchenne community.
- Develop a strong understanding of clinical practice as it relates to Duchenne.
- Participate in refining KOL mapping; develop and execute on a customer-centric tactical engagement plan to support Medical Affairs strategies.
- Gather and share scientific insights via scientific exchange to inform executable and innovative Medical Affairs strategies.
- Serve as a resource for addressing unsolicited medical questions about REGENXBIO's trials and investigational products.
- Provide clinical expertise in the development, management, and maintenance of clinical and scientific communications, including educational materials, meeting presentations and FAQs.
- Attend medical conferences as MA representative: assist with congress strategy / planning, medical booth staffing, competitive intelligence / insights gathering, and generating meeting summaries.
- Support Patient Advocacy conferences and outreach as requested.
- As a field-based position, you must be able to travel 50-70% of the time.
- It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships and using clear communication to meet shared objectives.
What we're looking for
- Master's degree (MPH or equivalent) required. Doctorate level (MD, PharmD, PhD) preferred.
- Minimum of 3 years of rare disease clinical or therapeutic experience in neuromuscular diseases, and/or gene therapy with primary emphasis on field based scientific exchange and/or clinical trial support.
- Minimum of 3 years of MSL experience with primary emphasis on field based scientific exchange and/or clinical trial support.
- Superior communication, relationship building and interpersonal skills.
- Ability to assimilate new clinical data quickly.
- Proactive problem-solving skills.
- Project management and medical writing skills.
- Flexibility, resilience, and creativity/innovation in their work.
- Ability to organize and lead high level projects.
- Ability to proactively predict issues and solve problems.
- Ability to work collaboratively with cross-functional teams.
Requirements
- Master's degree (MPH or equivalent) required
- Doctorate level (MD, PharmD, PhD) preferred
- Minimum of 3 years of rare disease clinical or therapeutic experience in neuromuscular diseases and/or gene therapy
- Minimum of 3 years of MSL experience
- Superior communication, relationship building and interpersonal skills
- Ability to assimilate new clinical data quickly
- Proactive problem-solving skills
- Project management and medical writing skills
- Flexibility, resilience, and creativity/innovation
- Ability to organize and lead high level projects
- Ability to proactively predict issues and solve problems
- Ability to work collaboratively with cross-functional teams
- Ability to travel 50-70% of the time
Benefits
- Annual Bonus Program
- Education Assistance
- Retirement Plan with Employer Match
- Stock Options
- Summer Hours
Company overview
REGENXBIO is a leading clinical-stage biotechnology company dedicated to improving lives through the curative potential of gene therapy. Founded in 2008 and headquartered in Rockville, Maryland, the company has pioneered the development of AAV (adeno-associated virus) Therapeutics, an innovative class of gene therapy medicines. REGENXBIO's proprietary NAV Technology Platform enables the discovery and development of recombinant AAV gene therapies designed to address genetic defects by delivering therapeutic genes to cells. The company's pipeline focuses on retinal diseases, neuromuscular disorders, and neurodegenerative conditions, with key programs including RGX-314 for wet AMD and diabetic retinopathy (in collaboration with AbbVie), RGX-202 for Duchenne muscular dystrophy, and RGX-121 for Mucopolysaccharidosis Type II (Hunter syndrome). REGENXBIO's technology has already demonstrated significant impact, with thousands of patients treated through its platform, including Novartis' ZOLGENSMA for spinal muscular atrophy. As a publicly traded company (NASDAQ: RGNX) with approximately 200-500 employees, REGENXBIO continues to advance its mission of developing one-time treatments that could transform healthcare delivery for millions of patients with genetic diseases.